|
Real-time
Oslo Bors
03:07:38 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 0.7900 NOK | +8.97% |
|
+5.33% | -42.75% |
| 09-03 | EXACT Therapeutics AS Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-30 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Drug Delivery Technologies | |||||||||
Research and Development of Acoustic Cluster Therapy (ACT) | 52K | 455K | 4.46K | - | 59K | ||||
Total Assets | 118M | 82.51M | 61.32M | 153M | 67.4M | ||||
Interest Expense | -100K | -98.93K | -85.64K | -54.46K | -34.89K | ||||
Income Tax Expense | - | -462K | -48.47K | - | - | ||||
CAPEX | -1.63M | -251K | -3.09M | -1.51M | -5.32M | ||||
EBT | -58.59M | -40.57M | -48.38M | -52.33M | -86.97M | ||||
D&A | 1.83M | 1.94M | 2.09M | 2.43M | 3.68M | ||||
Operating Income | -59.11M | -40.77M | -48.38M | -52.85M | -84.88M | ||||
Net Income | -58.59M | -40.1M | -48.33M | -52.33M | -86.97M |
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Norway | - | - | - | - | - | ||||
Total Assets | 5.66M | 4.53M | 3.57M | 18.53M | 5.29M | ||||
Interest Expense | - | - | - | - | - | ||||
D&A | - | - | - | - | - | ||||
CAPEX | - | - | - | - | - | ||||
Net Income | - | - | - | - | - | ||||
EBT | - | - | - | - | - | ||||
Operating Income | - | - | - | - | - | ||||
Total Assets | 670K | 443K | 1.85M | 1.47M | 1.6M |
- Stock Market
- Stocks
- EXTX Stock
- Financials EXACT Therapeutics
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
